Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As It Soaks Up Good Trial Results, Amarin Ponders Partners - Or None

This article was originally published in The Pink Sheet Daily

Executive Summary

A second set of clinical trial results expands the potential market for AMR101 tenfold, triggering increased investor and partnership interest.
Advertisement

Related Content

Amarin Raises $100M Debt Funding As It Preps For Vascepa Launch
Branded Life After Lipitor: Pharma Targets Unmet Needs In Dyslipidemia
Amarin Seeks AMR101 Approval; Hopes To Begin Commercialization Of First Product
Amarin Seeks AMR101 Approval; Hopes To Begin Commercialization Of First Product
Omthera Looks To Take Lead In Omega-3 Space, Armed With Data Showing Advantages Over Lovaza
Omthera Looks To Take Lead In Omega-3 Space, Armed With Data Showing Advantages Over Lovaza
Amarin Version 3.0 Weighs Its Options on Promising Omega-3 Pipeline
Amarin Version 3.0 Weighs Its Options on Promising Omega-3 Pipeline
Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?

Topics

Advertisement
UsernamePublicRestriction

Register

PS072135

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel